0114 232 9292 connect@medilink.co.uk

News

Medilink Corporate Partner Nabarro Releases Latest Report

Medilink Corporate Partner Nabarro has released their latest report 'Taking AIM: ambition and fear in the UK tech sector'.  For US technology companies with “unicorn” ambitions, listing on Nasdaq is seen as a natural step – a means to raise new capital for growth and to realise the investment of early investors. In the UK, the…
Read more

Medilink member Tissuemed announces TissuePatch™ approval in China

Leeds-based Medilink member Tissuemed Ltd has been granted regulatory approval of its TissuePatch™ range of ultra-thin surgical sealant films by the Chinese FDA (‘CFDA’). TissuePatch™ is the first and only synthetic sealant to be approved by the CFDA, giving Tissuemed sole access to a significant medical device market that is being driven by both an…
Read more

Exclusive offers for Medilink members

Medilink member Tailormade Sales are a professional telemarketing agency, who are offering fellow Medilink members exclusive offers off their services. • Tailormade Sales are able to offer Lead Generation services to Medilink members who are looking to create appointments using skilled telemarketing operatives and techniques. A 10% discount against a standard 3 month trial is…
Read more

Ceftolozane/tazobactam 30/10 now available from Medilink member Mast!

Medilink member Mast have recently announced the launch of a new addition to the Mastdiscs® stock cartridge range – Ceftolozane/tazobatam 30/10 (C/T40C), is now available! Merck (MSD) has launched the new intravenous antibiotic Zerbaxa® (Ceftolozane/tazobactam) in the UK for the treatment of complicated intra-abdominal infections, acute pyelonephritis and complicated urinary tract infections in nosocominal environments.…
Read more